Clinical Trial Update: Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) [Phase 2]

View source ↗

Summary

Phase II trial comparing maintenance temozolomide versus observation in stable or responding stage III/IV Non-Small Cell Lung Cancer. The study (P05146) was ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung
• Large Cell Carcinoma of the Lung
• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Carcinoma, Non-Small-Cell Lung, Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2012-03-26